TGFB1 and neoplasm: Due to the role of TGF-β in creating a tumour microenvironment conducive to growth and metastasis, as well as by hindering the infiltration of T lymphocytes into the tumour centre, blocking the action of this cytokine has become another therapeutic target [77].